Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$56.72 USD
+0.53 (0.94%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $56.60 -0.12 (-0.21%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Exact Sciences Corporation has a market cap of $10.64B, which represents its share price of $56.19 multiplied by its outstanding shares number of 189.32M. As a large-cap company, EXAS's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
EXAS 56.72 +0.53(0.94%)
Will EXAS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for EXAS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXAS
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?
EXAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
Other News for EXAS
EXAS rises 0.94% on October 3, leaving the technical picture intact
Stochastic Reached Overbought appears for EXAS after 0.43% move
EXAS: Barclays Raises Price Target to $65.00 Amid Overweight Rating | EXAS Stock News
Is EXAS likely to continue higher? MACD Bullish Signal Line Cross shows up after advancing 3.14%
Exact Sciences price target raised to $65 from $55 at Barclays